Genetic bases of progressive supranuclear palsy: The MAPT tau disease

Current Medicinal Chemistry

Volumn 18, Issue 17, 2011, Pages 2655-2660

  Borroni, Barbara ^a,c   Agosti, Chiara ^a   Magnani, Enrico ^a   Di Luca, Monica ^b   Padovani, Alessandro ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Genetics; Microtuble Associated Protein Tau; Mutations; Polymorphisms; Progressive Supranuclear Palsy; Tau

Indexed keywords

ARTICLE; ASTROCYTE; AUTOSOMAL DOMINANT DISORDER; GENE; GENE MUTATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOME ANALYSIS; HAPLOTYPE; HUMAN; MAPT GENE; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PATHOGENESIS; PROGRESSIVE SUPRANUCLEAR PALSY; TAUOPATHY;

ADULT; AGED; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; MUTATION; NEUROFIBRILLARY TANGLES; SUPRANUCLEAR PALSY, PROGRESSIVE; TAU PROTEINS; TAUOPATHIES;

EID: 79957958968     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986711795933722     Document Type: Article

References (67)

1. Bower, J.H.; Maraganore, D.M.; McDonnell, S.K.; Rocca, W.A. Incidence and distribution of parkinsonism in Olmsted County , Minnesota 1976-1999. Neurology, 1999, 52,1214-20. (Pubitemid 29177924)
2. Richardson, J.C.; Steele, J.C.; Olszewski, J. Supranuclear ophthalmoplegia, pseudobulbar palsy, nuchal dystonia and dementia. Trans. Am. Neurol. Assoc., 1963, 8,25-29.
3. Steele, J.C.; Richardson, J.C.; Olszewski, J. Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical supranuclear gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch. Neurol., 1964, 10,333-359.
4. Litvan, I.; Agid, Y.; Calne, D.; Campbell, G.; Dubois, B.; Duvoisin, R.C.; Goetz, C.G.; Golbe, L.I.; Grafman, J.; Growdon, J.H.; Hallett, M.; Jankovic, J.; Quinn, N.P.; Tolosa, E.; Zee, D.S. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology,1996, 47,1-9. (Pubitemid 26243849)
5. Williams, D.R.; de Silva, R.; Paviour, D.C.; Pittman, A.; Watt, H.C.; Kilford, L.; Holton, J.L.; Revesz, T.; Lees, A.J. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. Brain, 2005, 128,1247-58. (Pubitemid 40826179)
6. Hauwn, J.J.; Daniel, S.E.; Dickson, D.; Horoupian, D.S.; Jellinger, K.; Lantos, P.L.; McKee, A.; Tabaton, M.; Litvan, I. Preliminary NINDS neuropathological criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology, 1994, 44, 2015-19. (Pubitemid 24349498)
7. Daniel, S.E.; de Bruin, V.M.; Lees, A.J. The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy): a reappraisal. Brain, 1995, 118,759-70.
8. Josephs, K.; Dickson, D.W. Diagnostic Accuracy of Progressive Supranuclear Palsy in the Society for Progressive Supranuclear Palsy Brain Bank. Mov. Disord., 2003, 18,1018-26. (Pubitemid 37185209)
9. Spillantini, M.G.; Bird, T.D.; Ghetti, B. Frontotemporal dementia and Parkinsonism linked to chromosome 17: a new group of tauopathies. Brain Pathol., 1998; 8,387-402. (Pubitemid 28186074)
10. Goedert, M. Tau gene mutations and their effects. Mov. Disord., 2005, 20(Suppl 12),S45-52. (Pubitemid 41419554)
11. Williams, D.R.; Holton, J.; Strand, C.; Pittman, A.; de Silva, R.; Lees, A.J; Revesz, T. Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome. Brain, 2007, 130, 1566-76. (Pubitemid 47355935)
12. Magnani, E.; Fan, J.; Gasparini, L.; Golding, M.; Williams, M.; Schiavo, G.; Goedert, M.; Amos, L.A.; Spillantini, M.G. Interaction of tau protein with the dynactin complex. EMBO J., 2007, 26(21), 4546-54. (Pubitemid 350036634)
13. Goedert, M.; Spillantini, M.G.; Jakes, R.; Rutherford, D.; Crowther R.A. Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's Disease. Neuron, 1989, 3, 519-26.
14. Hutton, M.; Lendon, C.L.; Rizzu, P.; Baker, M.; Froelich, S., Houlden, H.; Pickering-Brown, S.; Chakraverty, S.; Isaacs, A.; Grover, A.; Hackett, J.; Adamson, J.; Lincoln, S.; Dickson, D.; Davies, P.; Petersen, R.C.; Stevens, M.; de Graaff, E.; Wauters, E.; van Baren, J.; Hillebrand, M.; Joosse, M.; Kwon, J.M.; Nowotny P.; Che, L.K.; Norton, J.; Morris, J.C.; Reed, L.A.; Trojanowski, J.; Basun, H.; Lannfelt, L.; Neystat, M.; Fahn, S.; Dark, F.; Tannenberg, T.; Dodd, P.R.; Hayward, N.; Kwok, J.B.; Schofield, P.R.; Andreadis, A.; Snowden, J.; Craufurd, D.; Neary, D.; Owen F; Oostra, B.A.; Hardy, J.; Goate, A.; van Swieten, J.; Mann, D.; Lynch, T.; Heutink, P. Association of missense and 50-splicesite mutations in tau with the inherited dementia FTDP-17. Nature, 1998, 393, 702-05.
15. Delacourte, A.; Robitaille, Y.; Sergeant, N.; Buée, L.; Hof, P.R.; Wattez, A.; Laroche-Cholette, A.; Mathieu, J.; Chagnon, P.; Gauvreau, D. Specific pathological Tau protein variants characterize Pick's disease. J. Neuropathol. Exp. Neurol., 1996, 55,159-68.
16. Lieberman, A.P.; Trojanowski, J.Q.; Lee, V.M.; Balin, B.J.; Ding, X.S.; Greenberg, J.; Morrison, D.; Reivich, M.; Grossman, M. Cognitive, neuroimaging, and pathological studies in a patient with Pick's disease. Ann. Neurol., 1998; 43, 259-65. (Pubitemid 28110130)
17. Lee, G.; Neve, R.L.; Kosik, K.S. The microtubule binding domain of tau protein. Neuron, 1989, 2,1615-1624.
18. Chambers, C.B.; Lee, J.M.; Troncoso, J.C.; Reich, S.; Muma, N.A. Overexpression of four-repeat tau mRNA isoforms in progressive sopranuclear palsy but not in Alzheimer's disease. Ann. Neurol.,1999, 46,325-32. (Pubitemid 29416270)
19. Takanashi, M.; Mori, H.; Arima, K.; Mizuno, Y.; Hattori, N. Expression patterns of tau mRNA isoforms correlate with susceptible lesions in progressive supranuclear palsy and corticobasal degeneration. Molecular Brain Research, 2002, 104,210-19.
20. de Silva, R.; Lashley, T.; Gibb, G.; Hanger, D.; Hope, A.; Reid, A.; Bandopadhyay, R.; Utton, M.; Strand, C.; Jowett, T; Khan, N.; Anderton, B.; Wood, N.; Holton, J; Revesz, T.; Lees, A. Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies. Neuropathol. Appl. Neurobiol., 2003, 29,288-302. (Pubitemid 36718177)
21. Liu, W.K.; Le, T.V.; Adamson, J.; Baker, M.; Cookson, N.; Hardy, J.; Hutton, M.; Yen, S.H.; Dickson, D.W. Relationship of the extended tau haplotype to tau biochemistry and neuropathology in progressive supranuclear palsy. Ann. Neurol., 2001, 50,494-502. (Pubitemid 32938894)
22. Gibb, G.M.; de Silva, R.; Revesz, T.; Lees, A.J.; Anderton, B.H.; Hanger, D.P. Differential involvement and heterogeneous phosphorylation of tau isoforms in progressive supranuclear palsy. Mol. Brain Res., 2004, 121,95-101. (Pubitemid 38224173)
23. Jellinger, K.A. Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy. Neurodegenerative Dis., 2008, 5, 339-46.
24. Paviour ,D.C.; Price, S.L.; Jahanshahi, M.; Lees, A.J.; Fox, N.C. Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy. Brain, 2006, 129:1040-49.
25. Williams, D.R.; Lees, J.R. Progressive Supranuclear Palsy: clinicopathological concept and diagnostic challenges. Lancet Neurol., 2009, 8,270-279.
26. Josephs, K.A.; Mandrekar, J.N.; Dickson, D.W. The relationship between histopathological features of progressive supranuclear palsy and disease duration. Parkinsonism Relat. Disord., 2006, 12,109-12. (Pubitemid 43234312)
27. Josephs, K.A.; Whitwell, J.L.; Dickson, D.W.; Boeve, B.F.; Knopman, D.S.; Petersen, R.C.; Parisi, J.E.;Jack, C.R. Jr. Voxel-based morphometry in autopsy proven PSP and CBD. Neurobiol. Aging 2008, 29(2), 280-9.
28. Rizzo, G.; Martinelli, P.; Manners, D.; Scaglione, C.; Tonon, C.; Cortelli, P.; Malucelli, E.; Capellari, S.; Testa, C.; Parchi, P.; Montagna, P.; Barbiroli, B.; Lodi, R. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease. Brain 2008, 131(Pt 10), 2690-700.
29. Agosta, F.; Kosti-, V.S.; Galantucci, S.; Mesaro-, S.; Svetel, M.; Pagani, E.; Stefanova, E.; Filippi, M. The in vivo distribution of brain tissue loss in Richardson's syndrome and PSP-parkinsonism: a VBM-DARTEL study. Eur. J. Neurosci. 2010 in press.
30. Goedert, M.; Crowther, R.A.; Spillantini, M.G. Tau mutations cause frontotemporal dementias. Neuron, 1998, 21(5),955-58. (Pubitemid 29018067)
31. Neary, D.; Snowden, J.S.; Gustafson, L.; Passant, U.; Stuss, D.; Black, S.; Freedman, M.; Kertesz, A.; Robert, P.H.; Albert, M.; Boone, K.; Miller, B.L.; Cummings, J.; Benson, D.F. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology, 1998, 51(6),1546-54.
32. McKhann, G.M.; Albert, M.S.; Grossman, M.; Miller, B.; Dickson, D.; Trojanowski, J.Q.; Work Group on Frontotemporal Dementia and Pick's Disease. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch. Neurol., 2001, 58(11),1803-1809. (Pubitemid 33044246)
33. Poorkaj, P.; Muma, N.A.; Zhukareva, V.; Cochran, E.J.; Shannon, K.M.; Hurtig, H.; Koller, W.C.; Bird, T.D.; Trojanowski, J.Q.; Lee, V.M.; Schellenberg, G.D. An R5L tau mutation in a subject with a progressive supranuclear palsy phenotype. Ann. Neurol., 2002, 52(4),511-16.
34. Stanford, P.M.; Halliday, G.M.; Brooks, W.S.; Kwok, J.B.; Storey, C.E.; Creasey, H.; Morris, J.G.; Fulham, M.J.; Schofield, P.R. Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene: expansion of the disease phenotype caused by tau gene mutations. Brain, 2000, 123( 5),880-93. (Pubitemid 30224185)
35. Halliday, G.M.; Song, Y.J.; Creasey, H.; Morris, J.G.; Brooks, W.S.; Kril, J.J. Neuropathology in the S305S tau gene mutation. Brain, 2006, 129( 3),E40.
36. Pastor, P.; Pastor, E.; Carnero, C.; Vela, R.; García, T.; Amer, G.; Tolosa, E.; Oliva, R. Familial atypical progressive supranuclear palsy associated with homozigosity for the delN296 mutation in the tau gene. Ann. Neurol., 2001, 49(2),263-67. (Pubitemid 32158006)
37. Rossi, G.; Gasparoli, E.; Pasquali, C.; Di Fede, G.; Testa, D.; Albanese, A.; Bracco, F.; Tagliavini, F. Progressive supranuclear palsy and Parkinson's disease in a family with a new mutation in the tau gene. Ann. Neurol., 2004, 55(3),448.
38. Pernaute, R.S.; Fontan, A.; Ruiz, P.G.; Honnorat, J.; Lynch, T.; Chin, S.; Gonzalo, I.; Rabano, A.; Martinez, A.; Daniel, S.; Pramstaller, P.; Morris, H.; Wood, N.; Lees, A.; Tabernero, C.; Nyggard, T.; Jackson, A.C.; Hanson, A.; de Yebenes, J.G. Clinical genetics of familial progressive supranuclear palsy. Brain, 1999, 122,1233-1245. (Pubitemid 29324845)
39. Thobois, S.; Streichenberger, N.; Kopp, N.; Sanchez, M.P.; Perez, M.; Hoenicka, J.; Avila, J.; Honnorat, J.; de Yebenes, J.G. A New Mutation of the {tau} Gene, G303V, in Early-Onset Familial Progressive Supranuclear Palsy. Arch. Neurol., 2005 62,1444-1450. (Pubitemid 41352063)
40. Spillantini, M.G.; Goedert, M.; Crowther, R.A.; Murrell, J.R.; Farlow, M.R.; Ghetti, B. Familial multiple system tauopathy with presenile dementia: a disease with abundant neuronal and glial tau filaments. Proc. Natl. Acad. Sci. USA, 1997, 94,4113-18. (Pubitemid 27180508)
41. Spina, S.; Farlow, M.R.; Unverzagt, F.W.; Kareken, D.A.; Murrell, J.R.; Fraser, G.; Epperson, F.; Crowther, R.A.; Spillantini, M.G.; Goedert, M.; Ghetti B. The tauopathy associated with mutation +3 in intron 10 of Tau: characterization of the MSTD family. Brain, 2008, 131,72-89.
42. Cruts, M.; Gijselinck, I.; van der Zee, J.; Engelborghs, S.; Wils, H.; Pirici, D.; Rademakers, R.; Vandenberghe, R.; Dermaut, B.; Martin, J.J.; van Duijn, C.; Peeters, K.; Sciot, R.; Santens, P.; De Pooter, T.; Mattheijssens, M.; Van den Broeck, M.; Cuijt, I.; Vennekens, K.; De Deyn, P.P.; Kumar-Singh, S.; Van Broeckhoven, C. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature, 2006, 442, 920-24. (Pubitemid 44285947)
43. Baker, M.; Mackenzie, I.R.; Pickering-Brown, S.M.; Gass, J.; Rademakers, R.; Lindholm, C.; Snowden, J.; Adamson, J.; Sadovnick, A.D.; Rollinson, S.; Cannon, A.; Dwosh, E.; Neary, D.; Melquist, S.; Richardson, A.; Dickson, D.; Berger, Z.; Eriksen, J.; Robinson, T.; Zehr, C.; Dickey, C.A.; Crook, R.; McGowan, E.; Mann, D.; Boeve, B.; Feldman, H.; Hutton, M. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature, 2006, 442, 916-19. (Pubitemid 44285946)
44. Skibinski, G.; Parkinson, N.J.; Brown, J.M.; Chakrabarti, L.; Lloyd, S.L.; Hummerich, H.; Nielsen, J.E.; Hodges, J.R.; Spillantini, M.G.; Thusgaard, T.; Brandner, S.; Brun, A.; Rossor, M.N.; Gade, A.; Johannsen, P.; Sørensen, S.A.; Gydesen, S.; Fisher, E.M.; Collinge. J. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat. Genet., 2005, 37(8),806-808.
45. Watts, G.D.; Wymer, J.; Kovach, M.J.; Mehta, S.G.; Mumm, S.; Darvish, D.; Pestronk, A.; Whyte, M.P.; Kimonis, V.E. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat. Genet., 2004, 36(4),377-81. (Pubitemid 38437260)
46. Conrad, C.; Andreadis, A.; Trojanowski, J.Q.; Dickson, D.W.; Kang, D.; Chen, X.; Wiederholt, W.; Hansen, L.; Masliah, E.; Thal, L.J.; Katzman, R.; Xia, Y.; Saitoh, T. Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann. Neurol., 1997, 41(2),277-81. (Pubitemid 27082112)
47. Baker, M.; Litvan, I.; Houlden, H.; Adamson, J.; Dickson, D.; Perez-Tur, J., Hardy, J.; Lynch, T.; Bigio, E.; Hutton, M. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum. Mol. Genet., 1999, 8(4),711-15. (Pubitemid 29139987)
48. Pastor, P.; Ezquerra, M.; Perez, J.C.; Chakraverty, S.; Norton, J.; Racette, B.A.; McKeel, D., Perlmutter, J.S.; Tolosa, E.; Goate, A.M. Novel haplotypes in 17q21 are associated with progressive supranuclear palsy. Ann. Neurol., 2004, 56(2),249-58. (Pubitemid 39037920)
49. Pittman, A.M., Myers, A.J.; Duckworth, J.; Bryden, L.; Hanson, M.; Abou- Sleiman, P.; Wood, N.W.; Hardy, J.; Lees, A., de Silva, R. The structure of the tau haplotype in controls and in progressive supranuclear palsy. Hum. Mol. Genet., 2004, 15,13(12),1267-74. (Pubitemid 38877880)
50. Rademakers, R.; Melquist, S.; Cruts, M.; Theuns, J.; Del-Favero, J.; Poorkaj, P.; Baker, M.; Sleegers, K.; Crook, R.; De Pooter, T.; Bel Kacem, S.; Adamson, J.; Van den Bossche, D.; Van den Broeck, M.; Gass, J.; Corsmit, E.; De Rijk, P.; Thomas, N.; Engelborghs, S.; Heckman, M., Litvan, I.M.; Crook, J.; De Deyn, P.P.; Dickson, D.; Schellenberg, G.D.; Van Broeckhoven, C.; Hutton, M.L. High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy. Hum. Mol. Genet., 2005, 14(21),3281-92. (Pubitemid 41631302)
51. Oliva, R.; Tolosa, E.; Ezquerra, M.; Molinuevo, J.L.; Valldeoriola, F.; Burguera, J.; Calopa, M.; Villa, M.; Ballesta, F. Significant changes in the tau A0 and A3 alleles in progressive supranuclear palsy and improved genotyping by silver detection. Arch. Neurol., 1998, 55(8),1122-1124. (Pubitemid 28367238)
52. Camuzat, A.; Romana, M.; Dürr, A.; Feingold, J.; Brice, A., Ruberg, M.; Lannuzel, A. The PSP-associated MAPT H1 subhaplotype in Guadeloupean atypical parkinsonism. Mov. Disord., 2008, 23(16),2384-91.
53. Conrad, C., Amano, N.; Andreadis, A.; Xia, Y.; Namekataf, K.; Oyama, F.; Ikeda, K.; Wakabayashi, K.; Takahashi, H., Thal, L.J.; Katzman, R.; Shackelford, D.A.; Matsushita, M.; Masliah, E.; Sawa, A. Differences in a dinucleotide repeat polymorphism in the tau gene between Caucasian and Japanese populations: implication for progressive supranuclear palsy. Neurosci. Lett., 1998,250(2),135-37. (Pubitemid 28348311)
54. Baba, Y.; Putzke, J.D.; Tsuboi, Y.; Josephs, K.A.; Thomas, N.; Wszolek, Z.K.; Dickson, D.W. Effect of MAPT and APOE on prognosis of progressive supranuclear palsy. Neurosci. Lett., 2006, 405(1-2),116-19. (Pubitemid 44142824)
55. Litvan, I.; Baker, M.; Hutton, M. Tau genotype: no effect on onset, symptom severity, or survival in progressive supranuclear palsy. Neurology, 2001, 57(1),138-40. (Pubitemid 32634866)
56. Pittman, A.M.; Myers, A.J.; Abou-Sleiman, P.; Fung, H.C.; Kaleem, M.; Marlowe, L.; Duckworth, J.; Leung, D.; Williams, D.; Kilford, L.; Thomas, N.; Morris, C.M.; Dickson, D.; Wood, N.W.; Hardy, J.; Lees, A.J.; de Silva, R. Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration. J. Med. Genet., 2005, 42,837-46. (Pubitemid 41598191)
57. Caffrey, T.M.; Wade-Martins, R. Functional MAPT haplotypes: bridging the gap between genotype and neuropathology. Neurobiol. Dis., 2007,27(1),1-10. (Pubitemid 46921479)
58. Di Maria, E.; Tabaton, M.; Vigo, T.; Abbruzzese, G.; Bellone, E.; Donati, C.; Frasson, E.; Marchese, R.; Montagna, P.; Munoz, D.G.; Pramstaller, P.P.; Zanusso, G.; Ajmar, F.; Mandich, P. Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy. Ann. Neurol,. 2000, 47(3),374-77. (Pubitemid 30141849)
59. Houlden, H.; Baker, M.; Morris, H.R.; MacDonald, N.; Pickering-Brown, S.; Adamson, J.; Lees, A.J.; Rossor, M.N.; Quinn, N.P.; Kertesz, A.; Khan, M.N.; Hardy, J.; Lantos, P.L.; St George-Hyslop, P.; Munoz, D.G.; Mann, D.; Lang, A.E.; Bergeron, C.; Bigio, E.H., Litvan, I.; Bhatia, K.P.; Dickson, D.; Wood, N.W., Hutton, M. Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology, 2001, 56(12),1702-06. (Pubitemid 32574570)
60. Pastor, P., Tolosa, E. Progressive supranuclear palsy: clinical and genetic aspects. Curr. Opin. Neurol., 2002, 15(4),429-37. (Pubitemid 34828119)
61. Higgins, J.J.; Litvan, I.; Pho, L.T.; Li, W.; Nee, L.E. Progressive supranuclear gaze palsy is in linkage disequilibrium with the tau and not the alpha-synuclein gene. Neurology, 1998, 50(1),270-73.
62. Morris, H.R.; Vaughan, J.R.; Datta, S.R.; Bandopadhyay, R.; De Silva, R.; Schrag, A.; Cairns, N.J.; Burn, D.; Nath, U; Lantos, P.L.; Daniel, S.; Lees, A.J.; Quinn, N.P.; Wood, N.W. Multiple system atrophy/progressive supranuclear palsy: alpha-Synuclein, synphilin, tau, and APOE. Neurology, 2000, 55(12),1918-20. (Pubitemid 32103980)
63. Borroni, B.; Ghezzi, S.; Agosti, C.; Archetti, S.; Fenoglio, C.; Galimberti, D.; Scarpini, E.; Di Luca, M.; Bresolin, N.; Comi, G.P.; Padovani, A.; Del Bo, R. Preliminary evidence that VEGF genetic variability confers susceptibility to frontotemporal lobar degeneration. Rejuvenation Res., 2008, 11(4),773-80.
64. Melquist, S.; Craig, D.W.; Huentelman, M.J.; Crook, R.; Pearson, J.V.; Baker, M.; Zismann, V.L., Gass, J., Adamson, J., Szelinger, S.; Corneveaux, J.; Cannon, A.; Coon, K.D.; Lincoln, S.; Adler, C.; Tuite, P., Calne, D.B.; Bigio, E.H.; Uitti, R.J.; Wszolek, Z.K.; Golbe, L.I.; Caselli, R.J., Graff- Radford, N., Litvan, I., Farrer, M.J.; Dickson, D.W.; Hutton, M.; Stephan, D.A. Identification of a novel risk locus for progressive supranuclear palsy by a pooled genomewide scan of 500,288 single-nucleotide polymorphisms. Am. J. Hum. Genet., 2007, 80(4),769-78. (Pubitemid 46564413)
65. Kaat, L.D.; Boon, A.J.; Azmani, A., Kamphorst, W., Breteler, M.M.; Anar, B.; Heutink, P.; van Swieten, J.C. Familial aggregation of parkinsonism in progressive supranuclear palsy. Neurology, 2009,73(2),98-105.
66. Bugiani, O.; Murrell, J.R.; Giaccone, G.; Hasegawa, M.; Ghigo, G.; Tabaton, M.; Morbin, M.; Primavera, A.; Carella, F.; Solaro, C.; Grisoli, M.; Savoiardo, M.; Spillantini, M.G., Tagliavini, F.; Goedert, M.; Ghetti, B. Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau. J. Neuropathol. Exp. Neurol., 1999, 58(6),667-77. (Pubitemid 29264946)
67. Bird, T.D. Frontotemporal dementia: genotypes, phenotypes and more problems to be solved. Neurobiol. Aging., 2001 , 22(1),113-14. (Pubitemid 32333004)